FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1851299822> ?p ?o ?g. }

• W1851299822 endingPage "1192" @default.
• W1851299822 startingPage "1185" @default.
• W1851299822 abstract "PURPOSE We have systemically analyzed, both in vitro and in vivo, the effect of 13-cis-retinoic acids (RA) on non-Hodgkin's lymphoma (NHL). METHODS The in vitro growth-inhibitory effect of 13-cis-RA was examined in 11 (T cell, five; B cell, six) lymphoma cell lines by a tetrazolium colorimetric assay. A pilot clinical trial with oral 13-cis-RA 1 mg/kg/d was conducted in a selected group of 18 lymphoma patients, of whom 16 had failed to respond to at least one regimen of intensive chemotherapy. The in vitro and in vivo effects of 13-cis-RA were correlated with immunophenotypes, RA-induced changes of morphology, and patterns of DNA fragmentation of the lymphoma cells. RESULTS Four of five T-lymphoma cell lines and none of six B-lymphoma cell lines were sensitive (concentration of 50% growth inhibition [IC50] < 1.5 microns) to 13-cis-RA (P = .015). In the clinical trial, five (two Ki-1, one angioinvasive type, one diffuse mixed cell, and one diffuse large cell) complete remissions and one (Ki1) partial remission were observed in 12 patients with peripheral T-cell lymphoma (PTCL), while none of six patients with B-cell lymphoma responded to 13-cis-RA. 13-cis-RA-induced cellular differentiation and apoptosis, as evidenced by the more mature morphology, characteristic nuclear condensation, and DNA ladder pattern signifying internucleosomal fragmentation, were demonstrated in the sensitive cell lines, as well as in the remitting lymphoma tissues. CONCLUSION The 13-cis-RA appears to be active on lymphomas of T-lineage and their therapeutic indication may be extended to include some subtypes of PTCL. The mechanisms of action are related to differentiation and apoptosis of lymphoma cells. There appears to be no cross-resistance between 13-cis-RA and conventional chemotherapy." @default.
• W1851299822 created "2016-06-24" @default.
• W1851299822 creator A5004699298 @default.
• W1851299822 creator A5007004865 @default.
• W1851299822 creator A5018112046 @default.
• W1851299822 creator A5038807397 @default.
• W1851299822 creator A5043678456 @default.
• W1851299822 creator A5044912783 @default.
• W1851299822 creator A5055582534 @default.
• W1851299822 creator A5065860060 @default.
• W1851299822 creator A5069590812 @default.
• W1851299822 creator A5076438797 @default.
• W1851299822 date "1994-06-01" @default.
• W1851299822 modified "2023-10-18" @default.
• W1851299822 title "Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study." @default.
• W1851299822 cites W1494503709 @default.
• W1851299822 cites W1511632497 @default.
• W1851299822 cites W1517291270 @default.
• W1851299822 cites W1554600230 @default.
• W1851299822 cites W1555688348 @default.
• W1851299822 cites W1589415602 @default.
• W1851299822 cites W1905059524 @default.
• W1851299822 cites W1963545910 @default.
• W1851299822 cites W1964651827 @default.
• W1851299822 cites W1982730855 @default.
• W1851299822 cites W1988833958 @default.
• W1851299822 cites W2027091722 @default.
• W1851299822 cites W2029372789 @default.
• W1851299822 cites W2030842924 @default.
• W1851299822 cites W2045417135 @default.
• W1851299822 cites W2089356314 @default.
• W1851299822 cites W2093467508 @default.
• W1851299822 cites W2101462909 @default.
• W1851299822 cites W2141307033 @default.
• W1851299822 cites W2152443283 @default.
• W1851299822 cites W2327237185 @default.
• W1851299822 cites W2336886126 @default.
• W1851299822 cites W2418186312 @default.
• W1851299822 cites W290812845 @default.
• W1851299822 doi "https://doi.org/10.1200/jco.1994.12.6.1185" @default.
• W1851299822 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8201381" @default.
• W1851299822 hasPublicationYear "1994" @default.
• W1851299822 type Work @default.
• W1851299822 sameAs 1851299822 @default.
• W1851299822 citedByCount "48" @default.
• W1851299822 countsByYear W18512998222013 @default.
• W1851299822 countsByYear W18512998222014 @default.
• W1851299822 countsByYear W18512998222015 @default.
• W1851299822 countsByYear W18512998222017 @default.
• W1851299822 countsByYear W18512998222018 @default.
• W1851299822 countsByYear W18512998222021 @default.
• W1851299822 countsByYear W18512998222022 @default.
• W1851299822 crossrefType "journal-article" @default.
• W1851299822 hasAuthorship W1851299822A5004699298 @default.
• W1851299822 hasAuthorship W1851299822A5007004865 @default.
• W1851299822 hasAuthorship W1851299822A5018112046 @default.
• W1851299822 hasAuthorship W1851299822A5038807397 @default.
• W1851299822 hasAuthorship W1851299822A5043678456 @default.
• W1851299822 hasAuthorship W1851299822A5044912783 @default.
• W1851299822 hasAuthorship W1851299822A5055582534 @default.
• W1851299822 hasAuthorship W1851299822A5065860060 @default.
• W1851299822 hasAuthorship W1851299822A5069590812 @default.
• W1851299822 hasAuthorship W1851299822A5076438797 @default.
• W1851299822 hasConcept C126322002 @default.
• W1851299822 hasConcept C142724271 @default.
• W1851299822 hasConcept C1491633281 @default.
• W1851299822 hasConcept C150903083 @default.
• W1851299822 hasConcept C190283241 @default.
• W1851299822 hasConcept C202751555 @default.
• W1851299822 hasConcept C203014093 @default.
• W1851299822 hasConcept C207001950 @default.
• W1851299822 hasConcept C2776694085 @default.
• W1851299822 hasConcept C2779338263 @default.
• W1851299822 hasConcept C31573885 @default.
• W1851299822 hasConcept C43759708 @default.
• W1851299822 hasConcept C502942594 @default.
• W1851299822 hasConcept C54355233 @default.
• W1851299822 hasConcept C55493867 @default.
• W1851299822 hasConcept C71924100 @default.
• W1851299822 hasConcept C81885089 @default.
• W1851299822 hasConcept C86803240 @default.
• W1851299822 hasConceptScore W1851299822C126322002 @default.
• W1851299822 hasConceptScore W1851299822C142724271 @default.
• W1851299822 hasConceptScore W1851299822C1491633281 @default.
• W1851299822 hasConceptScore W1851299822C150903083 @default.
• W1851299822 hasConceptScore W1851299822C190283241 @default.
• W1851299822 hasConceptScore W1851299822C202751555 @default.
• W1851299822 hasConceptScore W1851299822C203014093 @default.
• W1851299822 hasConceptScore W1851299822C207001950 @default.
• W1851299822 hasConceptScore W1851299822C2776694085 @default.
• W1851299822 hasConceptScore W1851299822C2779338263 @default.
• W1851299822 hasConceptScore W1851299822C31573885 @default.
• W1851299822 hasConceptScore W1851299822C43759708 @default.
• W1851299822 hasConceptScore W1851299822C502942594 @default.
• W1851299822 hasConceptScore W1851299822C54355233 @default.
• W1851299822 hasConceptScore W1851299822C55493867 @default.
• W1851299822 hasConceptScore W1851299822C71924100 @default.
• W1851299822 hasConceptScore W1851299822C81885089 @default.

• next